Work

PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer

Year: 2015

Type: article

Study design: Observational Study

Source: European Urology Focus

DOI: 10.1016/j.euf.2015.07.005

Authors: Tamara L. Lotan, Wei Wei, Carlos L. Morais, Sarah T. Hawley, Ladan Fazli, Antonio Hurtado-Coll, Dean Troyer, Jesse K. McKenney, Jeffrey Simko, Peter R. Carroll, Martin Gleave, Raymond Lance, Daniel W. Lin, Peter S. Nelson, Ian M. Thompson, Lawrence D. True, Ziding Feng, James D. Brooks

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital, The University of Texas MD Anderson Cancer Center, Canary Foundation, Vancouver Prostate Centre, Eastern Virginia Medical School, Cleveland Clinic, University of California, San Francisco, University of Washington, The University of Texas at San Antonio Health Science Center, Stanford Medicine, Stanford University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G111615301, G4183297229, Cancer Center Support Grant

OpenAlex ID: W2160971263

FWCI: 6.416

Cites: 46

Cited by: 75

Related to: 10